Trials / Completed
CompletedNCT00467870
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
A Two-Arm, Open-Label, Randomized, Multi-Center Pharmacokinetic and Long-Term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 531 (actual)
- Sponsor
- Endo Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the pharmacokinetics of TU 750 mg and TU 1000 mg via multiple measurements of serum total testosterone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone Undecanoate 750 mg | |
| DRUG | Testosterone Undecanoate 1000 mg |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2007-05-01
- Last updated
- 2017-10-05
- Results posted
- 2017-03-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00467870. Inclusion in this directory is not an endorsement.